First Time Loading...

eFFECTOR Therapeutics Inc
NASDAQ:EFTR

Watchlist Manager
eFFECTOR Therapeutics Inc Logo
eFFECTOR Therapeutics Inc
NASDAQ:EFTR
Watchlist
Price: 2.2258 USD 1.17% Market Closed
Updated: May 2, 2024

eFFECTOR Therapeutics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

eFFECTOR Therapeutics Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
eFFECTOR Therapeutics Inc
NASDAQ:EFTR
Cash from Financing Activities
$21.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is eFFECTOR Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
21.2m USD

Based on the financial report for Dec 31, 2023, eFFECTOR Therapeutics Inc's Cash from Financing Activities amounts to 21.2m USD.

What is eFFECTOR Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
667%

Over the last year, the Cash from Financing Activities growth was 667%.